Clin2
NCT04547348Possibly a fitRecruiting

Denosumab for healing an acute Charcot foot in diabetes

Charcot FootDiabetes Mellitus

Treatments studied

Part of Hormones & metabolism clinical trials.

This Phase 3 trial tests whether denosumab can improve healing and outcomes for people with an acute Charcot foot caused by diabetes-related nerve problems. You may be able to join if your Charcot foot is recently diagnosed and you meet specific safety and lab requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
38 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You’re between 18 and 80 years old.
  • You have type 1 or type 2 diabetes diagnosed for more than 3 months.
  • You have an acute Charcot foot in one foot only, with clear signs like redness, swelling, warmth, and confirmed Charcot changes on scans.
  • The Charcot episode must be 3 months or less at the screening visit.
  • You must not have a foot ulcer or a foot infection in the affected foot.
  • You must not have recent denosumab treatment, low calcium or vitamin D, significant kidney problems, or a history of jaw bone problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07139184Not yet recruiting
Charcot Foot Risk Factors in People with Diabetes

This study looks at why some people with diabetes develop a rare foot condition called Charcot foot, which causes weakened bones and joint damage. It focuses on inflammation and other health issues that may raise risk.

NCT05251480Not yet recruiting
DermGEN™ for diabetic foot ulcers in First Nations people

This trial studies whether DermGEN™ can help heal diabetic foot ulcers in First Nations participants. You may be asked to take part in wound care and wear a special cast, and the team will monitor your ulcer healing over time.

Emo, Ontario
NCT07271771Recruiting· Phase 4
Denosumab for muscle and insulin in diabetes

This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.

Aarhus
NCT07063797Not yet recruiting
Denosumab for diabetes patients at high risk of fracture

This trial tests if denosumab, a drug that strengthens bones, can help people with type 2 diabetes who have a high risk of breaking a bone. It is for patients who have had diabetes for a long time or have certain complications.

Beijing, Dongcheng
NCT05491577Recruiting
Diabetes foot nerve disease patients without ulcers

This study looks at what affects changes in quality of life in people with diabetes who have a long-term, wound-free Charcot foot. It may help doctors understand what matters most for day-to-day wellbeing in this condition.

Boulogne-sur-Mer, Pas-de-Calais
NCT06573554Recruiting
Comparing two casts for Charcot foot healing

This study compares two ways to take weight off a Charcot foot (a diabetic foot complication) — a special contact cast versus a removable back slab. The goal is to see which method helps your foot heal better.

Chandigarh

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.